Micromet, Inc. Reports First Quarter 2008 Financi... (luted net loss per share ...)

(Date:11/22/2009)...hysician-scientists from Weill Cornell Medical Col...y prove to be a powerful target for the treatment ...ffects lymphocytes, or white blood cells. By explo...o powerfully suppress tumor formation in lab testi...e led to the design of a clinical trial that will ...

(Date:11/22/2009)...& Machine post You Tube video demonstrating th... Landover, MD (PRWEB) Novemb...in learning what a really rugged waterproof keyboa...ool Keyboard vs Washable Competitors Keyboard HD&r...ow the premium, Really Cool Keyboard from Man &am...

(Date:11/21/2009)... Milvia Lopez, by her attorney MICH...led suit, in Supreme Court, New York County, beari... while Ms. Lopez underwent a routine transesophage...AL , doctors used an HIV infected scope exposing h...ral hours after being discharged from the procedur...

(Date:11/21/2009)...vative medical apparel company launches men,s lab ... San Clemente, Calif. (PRWEB) November 21,...cal apparel, today announced the launch of its men... a leading international trade fair for the medica...naugurates its men,s collection with three varying...

(Date:11/20/2009)...ist Closer to Understanding Brain Wiring and Disea...re/ -- Dr. Jeremy Schmahmann, Professor of Neurolo...e Massachusetts General Hospital in Boston, on Thu...earch on the new field of study called "Connectivi..., Dr. Schmahmann is an award-winning leader in the...

Breaking Medicine News(10 mins):Health News:New cancer target for non-Hodgkin's lymphoma 2 Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2 Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2 Health News:Medelita Introduces Men's Lab Coat Collection 2 Health News:Medelita Introduces Men's Lab Coat Collection 3 Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2

[0] New cancer target for non-Hodgkin's lymphoma [0] Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube [0] Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure [0] Medelita Introduces Men's Lab Coat Collection [0] MINDlink Foundation Launches to Connect the Cerebellum to Cures

...ory for patient-centered medical home model, WASH... Collaborative (PCPCC) released the following stat...e bill, which includes a provision,for a $100 mill... medical home demonstration projects in Medicare w...

... 10 Omnicell, Inc.,(Nasdaq: OMCL ), a leading pr...ilities, will hold a conference call Monday, July ...nancial results., What: Omnicell second quart... Rob Seim, chief financial officer Where: ...

...fect developing brain,s ability to make neural con...News) -- Common underlying mechanisms that affect ...gly disparate gene mutations found in autistic peo...ople that appear to be tied to inherited mutations...

...mproves Kidney Care in America--Increased,Kidney C...fit, WASHINGTON, July 10 In response to the,pass...dney Care Partners,(KCP) -- an alliance of patient...nd kidney failure -- applauded the United,States S...

...wing is a,statement by Mark J. Feldman, DMD, Presi...ncement that 70 percent of the U.S. population now...me this very encouraging news from the Centers for...and,scientific study that community water fluorida...

...prove Genetic Healthcare and Educate Patients, SA... and,Iverson Genetic Diagnostics, Inc. today annou...personalized reports for individuals receiving,Ive... for Iverson customers, allowing physicians who wo...

Other Medicine News:Health News:Omnicell to Release Second Quarter 2008 Earnings Results on July 21 2 Health News:Common Mechanisms May Contribute to Autism's Mutations 2 Health News:Kidney Community Applauds Senate for Passage of End Stage Renal Disease (ESRD) Improvements 2 Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 2 Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 3

Patient Centered Primary Care Collaborative Statement on Passage of Medicare Bill Omnicell to Release Second Quarter 2008 Earnings Results on July 21 Common Mechanisms May Contribute to Autism's Mutations Kidney Community Applauds Senate for Passage of End Stage Renal Disease (ESRD) Improvements Statement on CDC Announcement That 70 Percent of the U. S. Population Now Receives Optimally Fluoridated Water By Mark J. Feldman, DMD, President, American Dental Association DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results

(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire...(NYSE: BDX ) today announced the completion of i...chigan-based company that develops and manufacture...orms. ,, In May 2009, BD and HandyLab announced...ercialize molecular assays on the HandyLab Jaguar(...

(Date:11/19/2009)..., , BIRMINGHAM, Ala., Nov. 19 /PRNewswire-F...q: BCRX ) today announced the pricing of a public...at $9.75 per share, resulting in gross proceeds of...red by BioCryst pursuant to an effective shelf reg...rities and Exchange Commission. BioCryst has also...

(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswir...aq: ALXA ) announced today that its corporate pre...ual Piper Jaffray Health Care Conference on Wednes...The presentation will be webcast from The New York... Thomas B. King, Alexza President and CEO. ,,...

Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2 BD Completes Acquisition of HandyLab, Inc. 3 BioCryst Announces Pricing of Public Offering of Common Stock 2 BioCryst Announces Pricing of Public Offering of Common Stock 3 Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2 Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3 Binghamton Research Group Develops New Cancer Treatment 5010 1 Binghamton Research Group Develops New Cancer Treatment 5010 2 Binghamton Research Group Develops New Cancer Treatment 5010 3 Binghamton Research Group Develops New Cancer Treatment 5010 4 HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1 Reactive oxygens role in metastasis 9946 1 Reactive oxygens role in metastasis 9946 2

[0] BD Completes Acquisition of HandyLab, Inc.[0] BioCryst Announces Pricing of Public Offering of Common Stock [0] Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference

...ta Selected and Presented as,Platform Presentation...Technology,Demonstrates Optimal Functional Activit...-- Discovery,Laboratories, Inc. (Nasdaq:DSCO) anno...hase 2 clinical trial of Surfaxin(r),(lucinactant ...reatment of Bronchopulmonary Dysplasia (BPD) were ...

...May 8, 2007 - King,Pharmaceuticals, Inc. (NYSE:KG)... clinical trial for its ALTACE(R) (ramipril),diure...merican,Society of Hypertension,s Twenty-Second An...ay 19, 2007 at the Hyatt Regency Hotel,Chicago, I... for,review from 10 AM to 6 PM CDT. The Company pr...

Other Medicine Technology:Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 2 Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 3 Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 4 Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 5 Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 6 Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting 7 King Pharmaceuticals Announces Plan to Present Results from Phase,III Clinical Trial Evaluating ALTACE as Monotherapy and in,Combination with Hydrochlorothiazide at the American Society of,Hypertension Annual Meeting 2

Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting King Pharmaceuticals Announces Plan to Present Results from Phase,III Clinical Trial Evaluating ALTACE as Monotherapy and in,Combination with Hydrochlorothiazide at the American Society of,Hypertension Annual Meeting

...n advanced scientific formulation that provides po...ct Plus is based on the AREDS clinical trial, and ...g the role of lutein in eye health. Featuring low ...nt blend of antioxidant nutrients and delivers 15 ...

...is a scientifically advanced nutritional formulati...nd full body health. MacularProtect Complete is ba... research. It features a comprehensive multinutrie...ntioxidants, such as 10 mg of FloraGLO® lutein...

Oculair

Ocuvite® Eye Vitamins and Mineral Supplement

Medicine Products:

MacularProtect Plus®MacularProtect Complete® Powerful Protection for Macular & Full Body Health Oculair Ocuvite® Eye Vitamins and Mineral Supplement

Micromet, Inc. Reports First Quarter 2008 Financi...(luted net loss per share ...),Health